Two Russian-developed research peptides studied for opposite but complementary effects.
Semax and Selank come up together constantly in nootropic research, and for good reason: they were both developed in Russian neuroscience programmes, and they're studied for effects that are close to opposite — which is exactly why researchers pair them.
Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone), modified for stability. Research has examined it for BDNF (brain-derived neurotrophic factor) expression, dopaminergic signalling, and neuroprotective pathways. In practical research terms, the literature concerns attention, memory models, and mental drive.
Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory peptide. Its research profile centres on GABAergic signalling and anxiolytic activity. The detail that draws the most attention: studies have examined anxiolytic effects without the sedation associated with other calming compounds.
Focus without calm produces agitation; calm without focus produces lethargy. Because the two compounds are studied for these complementary halves, research protocols frequently examine them as a pair rather than in isolation — the same reasoning behind combination nasal-spray formats.
Both are short peptide chains, both are studied for effects on BDNF pathways (Semax more directly), and both are researched via intranasal administration in much of the published literature, which is studied for direct access along the olfactory route.
Research context only. Neither compound is a treatment; both are supplied for laboratory research use.
Explore cognitive research compounds →